SCHEMBL21821334

SCHEMBL21821334

CCC(NC(=O)CC(Nc1nc2ccccc2[nH]1)c1cccc(C(F)(F)F)c1)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITGA5 P08648 1/20 0.46
▸ ITGB6 P18564 1/20 0.46
▸ ITGB8 P26012 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ PIN1 Q13526 2/20 0.45
▸ HSD17B10 Q99714 1/20 0.41
▸ MTOR P42345 1/20 0.41
▸ CTSA P10619 2/20 0.40
▸ ITGB3 P05106 1/20 0.40
▸ ITGAV P06756 1/20 0.40
▸ TRPV4 Q9HBA0 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21821307 0.90 SMN1; SMN2 (0.48) ITGA5ITGB6ITGB8SMN1; SMN2NPC1
SCHEMBL21821305 0.90 SMN1; SMN2 (0.48) ITGA5ITGB6ITGB8SMN1; SMN2NPC1
SCHEMBL30645019 0.87 NPC1 (0.47) ITGA5ITGB6ITGB8SMN1; SMN2NPC1
SCHEMBL20743761 0.87 NPC1 (0.47) ITGA5ITGB6ITGB8SMN1; SMN2NPC1
SCHEMBL28531797 0.86 ITGA5 (0.42) ITGA5ITGB6ITGB8SMN1; SMN2NPC1
SCHEMBL28531799 0.86 ITGA5 (0.42) ITGA5ITGB6ITGB8SMN1; SMN2NPC1
SCHEMBL19283490 0.86 ITGA5 (0.45) ITGA5ITGB6ITGB8SMN1; SMN2NPC1
SCHEMBL21821310 0.86 ITGA5 (0.45) ITGA5ITGB6ITGB8SMN1; SMN2NPC1
SCHEMBL19283613 0.86 ITGB6 (0.55) ITGA5ITGB6ITGB8SMN1; SMN2NPC1
SCHEMBL19301055 0.86 ITGA5 (0.47) ITGA5ITGB6ITGB8SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3419973-B1 NOVEL POTASSIUM CHANNEL INHIBITORS ACESION PHARMA APS (DK) 2020-04-08 — — EP disclosed
Send feedback